bio nutrition glp 1 GLP-1 therapy is reshaping metabolic care — and as professionals, we need to be ready for it. 💉🥗 The questions are getting more complex: How do we adapt dietary protocols for GLP-1 therapies are transforming weight

Medicaid coverage for GLP-1 obesity drugs varies by state

[17] Yet, at the same time, GLP-1s appeared to protect against late-stage retinopathy when compared with insulin

NICE recommendations for GLP-1 therapy include: For type 2 diabetes (NICE NG28): GLP-1 therapy should only be continued if there is a beneficial metabolic response (HbA1c reduction of 11 mmol/mol [1.0%] and weight loss of 3% of initial body weight at 6 months)

Injectables may be reserved for acute, hospital-based situations or severe oxidative stressbut are not ideal for long-term outpatient management

Because of the safety concerns and lack of approval, it should be approached with caution and medical guidance

Webster-Clark, M